Sources Sought Notice for Methotrexate Assays Reagents compatible with the Government-owned Roche Diagnostics Corporation Automated Clinical Chemistry Analyzers
The Medical Regional Contracting Office, West (MRCO-W) is issuing this Sources Sought Notice to find potential sources to provide Methotrexate Assays Reagents compatible with the Government-owned Roche Diagnostics Corporation Automated Clinical Chemistry Analyzers for the Brooke Army Medical Center (BAMC) Department of Pathology and Area Laboratory Services Microbiology Laboratory, Fort Sam Houston, Texas. A base period of performance of twelve (12) months plus four (4) twelve (12) month option periods are contemplated. THIS IS NOT A SOLICITATION ANNOUNCEMENT – This is a Sources Sought Notice and is issued solely for information and planning purposes – it does not constitute a Request for Quote (RFQ) or a promise to issue an RFQ in the future. Solicitations are not available at this time and requests for a solicitation will not receive a response. This notice does not constitute a commitment by the United States Government to contract for any supply or service whatsoever. All information submitted in response to this announcement is voluntary; the United States Government will not pay for information requested nor will it compensate any respondent for any cost incurred in developing information provided to the United States Government. Not responding to this Sources Sought Notice does not preclude participation in any future RFQ, should one be issued. It is the responsibility of the potential offerors to monitor this site for additional information pertaining to this requirement. The Government will use responses to this notice in formulating its acquisition strategy. If the Government does not receive sufficient information in response to this notice to verify the potential for competition exists, it is possible that a sole-source contract, supported by a Justification and Approval document, will be issued to support the Government's requirement. MRCO-W is seeking the following information (please answer paragraph below with your response): Company name, DUNS number, CAGE code, and point of contact information (including phone number and email address), and socio-economic category(ies) as related to NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing), such as 8(a), HUBZone, Women-Owned, Service-Disabled Veteran-Owned, Small, or Other-than-Small. Capability Statement (limited to ten pages), describing how your company meets the below objectives, providing additional proof (such as FDA approval) where appropriate: Our customer, the Department of Pathology, Core Laboratory Section, Reference Chemistry Laboratory at the main hospital located at BAMC and surrounding area clinics require the following reagents, supplies, calibrators, controls and materials: The reagents should: Must be FDA approved Must be compatible with current Roche analyzers Must provide reliable results Must provide QC materials Must provide calibration materials The response due date for this Sources Sought Notice is 4:00 PM CST on Wednesday, December 21, 2022. All questions and comments regarding this announcement shall be submitted via e-mail to the below POCs: W81K00-18-P-0612 Department of the Army Medical Command
12/6/22, 10:25 AM Notice of Intent to Sole Source - W81K00-23-Q-0106 - Methotrexate Assays Reagents compatible with the Government-owned Roche Diagnostics Corporation Automated Clinical Chemistry Analyzers
The Government’s requirement is to obtain methotrexate reagents, calibrators, controls and consumables under a cost-per-kit via a firm fixed price contract for the Department of Pathology and Area Laboratory Services, Brooke Army Medical Center (BAMC). The cost-per-kit arrangement will provide the necessary reagents, calibrators and controls compatible with the laboratory’s existing Roche Diagnostics Corporation chemistry analyzers at a set price for the base year and four option years to produce the patients test results. 18-P-0612 Department of the Army Medical Command
8/31/23, 11:16 AM Methotextrate Reagent Assay Kits
The USA Health Contracting Activity Regional Health Contract Office - Central solicited a Full and Open competition for purchase order under W81K00-18-Q-0175. This notice is to inform all interested parties that the sole source solicitation resulted in the award of one (1) purchase order to Ark Diagnostics Inc. Contract Number W81K00-18-P-0612, in the amount of $706,192.00. ARK DIAGNOSTICS, INC. 48089 FREMONT BLVD FREMONT, CA 94538-6541 Should you have any questions, please contact me at Marvin.B.Baker.civ@mail.mil.. Awarded Vendors: Ark Diagnostics. Inc.. Contract Award Dollar Amount: $706,192.00. Contract Award Date: 2018-09-25. W81K00-18-P-0612 Department of the Army Medical Command
9/26/18, 1:57 PM